The Department of Cancer Research (hereafter DoCR) aims to be instrumental in the development and execution of world-class research within prioritized areas based on previous strong intradepartmental scientific track records. The strategic research domains within the department are outstanding preclinical/translational research within the fields of Neuro-Oncology, Immuno-Oncology and Immunotherapies and Tumour Resistance Mechanisms. The department should also represent a knowledge hub and a training ground for the next generation of cancer researchers in Luxembourg and is responsible for the articulation of the research program of Luxembourg’s national cancer initiative, the “Plan Cancer”.
As a member of the executive management committee and Scientific Steering Committee of LIH, the Director is responsible for the overarching research activities and research strategy of the Department of Cancer Research, and contributing to transversal research initiatives of the LIH, which entails the following activities: